News
Artificial intelligence tools can assist emergency room physicians in accurately predicting disease, but only for patients ...
Examine current tools and technologies available to study brain-body connections and how large-scale data collection efforts, ...
The published long-term data suggests that the treatment could maintain its dominant position in the CF market.
Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in ...
President Biden’s metastatic prostate cancer diagnosis is a reminder for everyone to get regular checkups, get screened ...
“This is the first truthful presentation we have had on street medicine yet,” Perkins said following Shell’s presentation.
2025 — Insilico Medicine ("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the company will present an oral presentation and ...
announced its selection to present at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit on May 13-15, 2025, in Boston, MA. The presentation, titled "Improving Patient ...
Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results